Abstract: To know the prevalence of HBV, HCV, and HIV infection in multitransfused thalassemic
I. Introduction
Regular blood transfusion in patients with thalassemia, has improved their overall survival, but carries a definite risk of acquisition of blood-borne viral infections, especially viral hepatitis. Nowadays, vaccination against hepatitis B has efficiently been able to restrict the transmission of hepatitis B virus (HBV) infection. However, post-transfusion transmission of hepatitis C virus (HCV) has still remained a major health concern in thalassemic patients. In addition, since marked liver iron overload, which is often inevitable in patients on regular blood transfusion, and HCV infection have been shown to have a potentiating effect on hepatic fibrogenesis in thalassemic patients. [1] Chronic hepatitis C has been indicated as a progressive disease that dramatically increases the morbidity and mortality rates among these patients due to liver failure or hepatocellular carcinoma. [2] The prevalence of HCV infection among thalassemic patients has been reported to be up to 60% in Italy, [3] although the compulsory screening of donated bloods has decreased the incidence of both posttransfusion HBV and HCV infections. [4] A study in Thailand showed that the patients with anti-HCV antibodies had significantly abnormal liver function test. However, there were also significant correlations between iron status as indicated by transferrin saturation or serum ferritin levels and SGOT, SGPT, and 3-glutamyltransferase (GGT) levels. [5] We conducted this study to provide a comprehensive data bank on the epidemiology of HBV, HCV, and human immunodeficiency virus (HIV) infections in patients with β-thalassemia in west Bengal & their effects on liver function have also been determined.
II. Materials and Methods
This Cross-sectional Observational Study was carried out in Inpatient pediatric ward in a tertiary care hospital, Medical College, Kolkata for one year. One hundred patients with β-thalassemia major up to 12 years of age from eight districts of West Bengal including Kolkata(n=15), Hoogly(n=17), Howrah(n=23), 24Parganas-N(n=10), 24Parganas-S(n=10), PaschimMidnipur(n=15), PurbaMedinipur(n=7), Purulia(n=3) admitted in our in-patient pediatric ward, for blood transfusion were enrolled in this study. All enrolled patients had history of more than 10 blood transfusions. Patients with a history of less than 10 blood transfusions, doubtful diagnosis and unwilling patients or parents were excluded from our study. Initial data including confirmation of diagnosis by hemoglobin electrophoresis, transfusion history and previous medical history including vaccination, splenectomy etc was obtained by reviewing medical records and interviews. Thereafter, venous blood samples were obtained from each patient before blood transfusion and were sent for standard ELISA test for HIV, Surface antigen (HbsAg) for HBV and IgM Anti HCV antibody for HCV along with Liver Function Test (LFT).
The study protocol was approved by our institutional review board and informed written consent was taken from parents of each patient involved.
Results are expressed as mean ± standard deviation (SD). Comparison between two groups was made using the Student's t test for continuous variables. A P value < 0.05 was considered statistically significant. All statistical analyses were performed using SPSS software for Windows (version 10.0; SPSS Inc. Chicago, IL, USA).
III. Results and Analysis
Of the total 100 multitransfused children included in the study, 61 were males and 39 were females. Maximum cases of seropositivity were found among the patients of Howrah district followed by Kolkata, Paschim Medinipur, Hoogly and Purulia respectively. Of the total 100 cases, 15 cases were positive for HIV, 25 cases were positive for HCV and 5 cases for HBV. 7 cases were positive for both HIV and HCV and 3 cases were positive for HIV, HCV and HBV. (Table I) Maximum number of children have been receiving transfusion from 6 to 8 years (28 children) and the maximum prevalence of infection (20 children)were also noted in this group. Only 10 children have been receiving transfusion for less than 2 years and of them only 1 case of seropositivity was noted. There is an increasing tendency of infection till 6 to 8 years duration of transfusion.
There was no significant relationship between the presence of anti-HCV antibodies and the number and frequency of blood transfusions. Patients with anti-HCV antibodies, anti-HIV antibodies had significantly abnormal liver functions, such as higher levels of serum aspartate aminotransferase (SGOT) and alanine aminotransferase (SGPT) with P< 0.001 &P< 0.005 respectively, and lower levels of serum albumin compared with patients without anti-HCV &/or anti-HIV antibodies. (Table II) 
IV. Discussion
We carried out this study on children with β-thalassemia major from various districts of West Bengal to provide a comprehensive epidemiologic data on HBV, HCV, and HIV infections among thalassemic population of West Bengal. In this study, we revealed that 35 % of β-thalassemia major patients were HCV infected, which is very much higher than the prevalence among general population in Eastern India (1.85%). [6] Similarly, a high prevalence of HIV infection was noted (25%), which is pretty higher than the prevalence in thalassemic patients in India (8.9%) was reported previously. [7] Five percent of our patients were HBsAg positive, which is little higher than the value reported from the general population (2.97%) of Eastern India. [8] High seroprevalence of these infections may be due to lack of anti-HCV screening of blood products in the blood banks in Government and private sector, proper screening in the blood banks using Third and Fourth generation ELISA test is not done correctly or may be the kits labelled as ELISA are at fault. Professional donors are also on the increase than voluntary donors.
Patients with anti-HCV antibodies and anti-HIV antibodies had significantly abnormal liver functions and there were also significant correlations between iron status as indicated by serum ferritin levels and SGOT, SGPT levels. The findings suggest that HCV, HIV and iron overload are the main causes of abnormal liver function in these patients with thalassemia.
